Garvan announces the purchase of Irys Technology from BioNano GenomicsMEDIA RELEASE: 04 Dec 2013 Garvan today announced that it has elected to incorporate Irys technology from BioNano Genomics into its disease research programs, with particular emphasis on improving understanding of prostate cancer. With this purchase, Garvan becomes the first Early Access user of an Irys System in Australia. More
Genomics expert to assume Petre Foundation Chair of Prostate Cancer ResearchMEDIA RELEASE: 29 Nov 2013 The Garvan Institute and the University of Sydney are proud to announce that from January 2014 Professor Vanessa Hayes will assume the inaugural Petre Foundation Chair of Prostate Cancer Research. Professor Hayes heads the Laboratory for Human Comparative and Prostate Cancer Genomics at Garvan. She also holds a position as Professor of Genomic Medicine at the J. Craig Venter Institute in San Diego, California. More
Daniel Christ recognised with NHMRC Excellence Award28 Nov 2013 Garvan immunologist Dr Daniel Christ has been recognised by the National Health and Medical Research Council (NHMRC) as one of the top-ranked applicants in the 2012 round of grant and fellowship awards. Last night Dr Christ received his Excellence Award at the Academy of Science in Canberra. The award winners represent the top 20 out of 5236 peer reviewed applicants for funding in 2012. More
The deadly news about all osteoporotic fracturesMEDIA RELEASE: 28 Nov 2013 It is well known that hip and vertebral fractures increase the risk of premature death. Until now, little has been known about the clinical impact of non-hip, non-vertebral fractures – so new Garvan research showing that they may also increase the risk of death will better inform treatment. More
Angela Chou and Lee Marshall win 2013 Castle Harlan Award15 Nov 2013 Dr Angela Chou and Lee Marshall share this year’s $10,000 USD Castle Harlan Award for being the most outstanding early career PhD students at Garvan in 2013. Pathologist Angela Chou has been performing a detailed analysis of two potentially treatable subtypes of pancreatic cancer. Lee Marshall is undertaking a genome-wide study of several regions of the brain that confer susceptibility to Parkinson’s Disease, to find biomarkers that might be used to screen for the disease at an early stage and to identify potential therapeutic targets. More
Understanding immune system memory – in a roundabout wayMEDIA RELEASE: 11 Nov 2013 While the principle of immune memory has been known for decades, the exact molecular mechanisms underpinning it have remained a mystery. Garvan scientists have now unraveled part of that mystery, identifying the role of a gene called STAT3, which acts as a kind of roundabout, directing chemical messenger molecules to various destinations. More
Molecular interplay explains many immunodeficienciesMEDIA RELEASE: 10 Nov 2013 Garvan scientists have described an exquisitely balanced interplay of four molecules that trigger and govern antibody production in immune cells. As well as being an important basic science discovery, it helps explain why people with mutations in any one of the associated genes cannot fight infection effectively, and develop rare and crippling immunodeficiency disorders. More
How fat could help solve part of the diabetes problemMEDIA RELEASE: 29 Oct 2013 The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat – except when we start to develop diabetes, and insulin production slows down. Sydney scientists describe how a fat recycling system within pancreatic ‘beta cells’ determines the amount of insulin they secrete, and so may provide a target for future diabetes therapies. More
FRACTURE RISK CALCULATOR
Based on data from the 18-year Dubbo Osteoporosis Epidemiology Study. For men and women 60 years and over to assess their individual risk of fracture.
AUSTRALIAN PANCREATIC CANCER GENOME INITIATIVE
Garvan is involved in the Australian arm of the The International Cancer Genome Consortium – by investigating pancreatic cancer. For more information click here.